Persistent Corneal Epithelial Defect Study

Study Details

Participants in this clinical trial will receive the investigational study drug aimed at promoting corneal healing. The study will closely monitor the drug’s effectiveness and safety through regular assessments conducted by a team of medical professionals.

During the trial, participants will attend scheduled visits for check-ups and to track changes in their condition. The study aims to determine whether the investigational

Interventions:

Administration of the investigational study drug designed to promote healing in persistent corneal epithelial defects.

Do you meet the criteria and want to join the study?

If you meet the criteria and are interested in contributing to this important research, you may qualify for this study. For more information or to discuss your eligibility, please contact the Haltha team at Haltha Connect.